派格生物医药(杭州)股份有限公司(股票代码：02565)于2026年8月5日公告了截至2026年7月31日的股份变动月报表。公告显示，本月公司已发行股份及注册股本均未发生新增发行或减少，股本保持稳定。
根据公告，公司主要股本结构包括H股和非上市股份。其中，H股数量为386,002,390股，面值均为每股人民币1元，于月末总股本为386,002,390股；非上市股份数量为5,089,142股，面值均为每股人民币1元，期末合计股本5,089,142股。公司本月底注册股本总额记为人民币391,091,532元，相比上月底并无增减变动。
股份变动方面，7月未发生新的发行、购回或注销，也未公布任何期权、股权激励计划、可换股票据或权证的行权、失效及变动。公司同时确认，其面向公众持股比例符合香港联交所《上市规则》的相关规定。
公告由联席公司秘书黄一峰签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.